Caribou Biosciences, Inc. (CRBU) Tops Q3 EPS by 5c

Caribou Biosciences, Inc. (NASDAQ: CRBU) reported Q3 EPS of ($0.30), $0.05 better than the analyst estimate of ($0.35). Revenue for the quarter came in at $2.2 million versus the consensus estimate of $2.23 million.

For earnings history and earnings-related data on Caribou Biosciences, Inc. (CRBU) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Texas AG Paxton announces ongoing investigation into Carnival over data breach
• Apple investigating exposure to Tata Electronics data breach, full analysis underway - Reuters